Trial intelligence / Profile preview

Docetaxel Plus Cisplatin with Radiotherapy for Postoperative Cervical Cancer

NCT01999933Phase 3Unknown

Start
Nov 2013
Primary completion
Nov 2016
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of docetaxel in Cervical Cancer (CC). Status: unknown.

02

Drugs

docetaxel
03

Conditions

Cervical Cancer (CC)

Beyond the preview

Go deeper on NCT01999933.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01999933.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call